Anthera Pharmaceuticals Inc.
This article was originally published in Start Up
Executive Summary
The founder of Peninsula Pharmaceuticals brought investors huge multiples fast by exploiting trans-Pacific dealmaking opportunities. He's now following the same route with Anthera Pharmaceuticals in hopes of repeating his earlier success.
You may also be interested in...
Start-Up Previews (5/07)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: In Inflammation, the Indication's the Thing, features profiles of Anthera Pharmaceuticals, Logical Therapeutics, Opsona Therapeutics and VLST Corp.. Plus these Start-Ups Across Health Care: Biodesy, Magenta Medical and NuLens.
In Inflammation, the Indication's the Thing
With a host of drugs on the market for large inflammatory disease indications like rheumatoid arthritis, start-ups are finding niches elsewhere.
Start-Up Previews (5/07)
A preview of the emerging health care companies profiled in the current issue of Start-Up. This month's profile group: In Inflammation, the Indication's the Thing, features profiles of Anthera Pharmaceuticals, Logical Therapeutics, Opsona Therapeutics and VLST Corp.. Plus these Start-Ups Across Health Care: Biodesy, Magenta Medical and NuLens.